Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Model-Informed Immunogenicity Assessment of Nivolumab as Monotherapy and in Combination with Ipilimumab
Zhao, Yue, Li, Li, Ma, Jessica, Roy, Amit, Bello, Akintunde, Sheng, Jennifer, Hamuro, Lora
Published in The AAPS journal (25.04.2025)
Published in The AAPS journal (25.04.2025)
Get full text
Journal Article
A randomized, double-blind, single-dose study (LAVENDER) to assess the safety, tolerability, pharmacokinetics, and immunogenicity of a combined infusion of ABP 980 and pertuzumab in healthy subjects
Hanes, Vladimir, Chow, Vincent, Stewart, Tina, Puri, Adeep
Published in Cancer chemotherapy and pharmacology (01.11.2021)
Published in Cancer chemotherapy and pharmacology (01.11.2021)
Get full text
Journal Article
Phase I clinical trial of a five-peptide cancer vaccine combined with cyclophosphamide in advanced solid tumors
Murahashi, Mutsunori, Hijikata, Yasuki, Yamada, Kazunari, Tanaka, Yoshihiro, Kishimoto, Junji, Inoue, Hiroyuki, Marumoto, Tomotoshi, Takahashi, Atsushi, Okazaki, Toshihiko, Takeda, Kazuyoshi, Hirakawa, Masakazu, Fujii, Hiroshi, Okano, Shinji, Morita, Masaru, Baba, Eishi, Mizumoto, Kazuhiro, Maehara, Yoshihiko, Tanaka, Masao, Akashi, Koichi, Nakanishi, Yoichi, Yoshida, Koji, Tsunoda, Takuya, Tamura, Kazuo, Nakamura, Yusuke, Tani, Kenzaburo
Published in Clinical immunology (Orlando, Fla.) (01.05.2016)
Published in Clinical immunology (Orlando, Fla.) (01.05.2016)
Get full text
Journal Article